Onco is an international, peer-reviewed, open access journal on the whole field of oncotargets and cancer therapies research published quarterly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • Rapid Publication: first decisions in 15 days; acceptance to publication in 3 days (median values for MDPI journals in the first half of 2022).
  • Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
  • Onco is a companion journal of Cancers.
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Biology, Cancers, Current Oncology, Nanomaterials, Onco
Proteins for Targeting and Delivering Therapeutic Nanomaterials Topic Editors: Diana Díaz-García, Santiago Gómez-Ruiz
Deadline: 15 December 2022
Topic in AI, Cancers, Current Oncology, Diagnostics, Onco
Artificial Intelligence in Cancer Diagnosis and Therapy Topic Editors: Hamid Khayyam, Ali Madani, Rahele Kafieh, Ali Hekmatnia
Deadline: 20 December 2022
Topic in Biology, Cancers, Current Oncology, IJERPH, Onco
Soft Tissue Sarcomas: Treatment and Management Topic Editors: Shinji Miwa, Po-Kuei Wu, Hiroyuki Tsuchiya
Deadline: 31 January 2023
Topic in Cancers, IJMS, JPM, Onco, Pharmaceuticals
Pharmacogenetics: A Tool in Cancer Therapy Topic Editors: Stefania Crucitta, Gloria Ravegnini, Rossana Roncato
Deadline: 15 March 2023
Special Issue in Onco
Feature Papers in Onco Guest Editor: Fred Saad
Deadline: 31 December 2022
Special Issue in Onco
Non-coding RNAs in Cancer Genesis, Progression, and Therapy Guest Editors: Danny N. Dhanasekaran, Ciro Isidoro, Yong Sang Song
Deadline: 10 May 2023
Back to TopTop